Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Clinical Trials News- ERT Launches Centralized Cardiac Safety 2.0: A New Approach to ECG Management in Clinical Trials
- Paragon and NextDocs Introduce Clinical Optimization Solutions Targeting Life Sciences Firms
- CRL Offers Clients Global Services Integrated Structure
- Quintiles Extends Phase I Capacity and Capabilities
- Ricerca Biosciences Finalizes Acquisition of MDS Pharma Services Business
Blogroll
-
Meta
Tag Archives: Amgen
GSK Signs $120M Deal to Market DMab Overseas
Image via Wikipedia
In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval.
GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Posted in Deals, News, Technology Also tagged Australia, Canada, denosumab, Dmab, GlaxoSmithKline, Market, Mexico, New Zealand, sales force, U.S. Food and Drug Administration, United States Leave a comment

Saving Haiti: One Donation at a Time (UPDATED 1/21)